Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF BRAZIL HEARING AIDS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE BRAZIL HEARING AIDS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 BRAZIL HEARING AIDS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 BRAZIL HEARING AIDS MARKET, BY PRODUCT TYPE
16.1 OVERVIEW
16.2 HEARING AID DEVICES
16.2.1 RECEIVER-IN-THE-EAR HEARING AIDS
16.2.1.1. MICRO RIC/RITE
16.2.1.1.1. RECHARGABLE
16.2.1.1.1.1 MARKET VALUE (USD MN)
16.2.1.1.1.2 MARKET VOLUME (UNITS)
16.2.1.1.1.3 AVERAGE SELLINF PRICE (USD)
16.2.1.1.2. NON-RECHARGABLE
16.2.1.1.2.1 MARKET VALUE (USD MN)
16.2.1.1.2.2 MARKET VOLUME (UNITS)
16.2.1.1.2.3 AVERAGE SELLINF PRICE (USD)
16.2.1.2. STANDARD RIC/RITE
16.2.1.2.1. RECHARGABLE
16.2.1.2.1.1 MARKET VALUE (USD MN)
16.2.1.2.1.2 MARKET VOLUME (UNITS)
16.2.1.2.1.3 AVERAGE SELLINF PRICE (USD)
16.2.1.2.2. NON-RECHARGABLE
16.2.1.2.2.1 MARKET VALUE (USD MN)
16.2.1.2.2.2 MARKET VOLUME (UNITS)
16.2.1.2.2.3 AVERAGE SELLINF PRICE (USD)
16.2.2 BEHIND-THE-EAR HEARING AIDS
16.2.2.1. MINI BEHIND-THE EAR (BTE)
16.2.2.1.1. RECHARGABLE
16.2.2.1.1.1 MARKET VALUE (USD MN)
16.2.2.1.1.2 MARKET VOLUME (UNITS)
16.2.2.1.1.3 AVERAGE SELLINF PRICE (USD)
16.2.2.1.2. NON-RECHARGABLE
16.2.2.1.2.1 MARKET VALUE (USD MN)
16.2.2.1.2.2 MARKET VOLUME (UNITS)
16.2.2.1.2.3 AVERAGE SELLINF PRICE (USD)
16.2.2.2. STANDARD BEHIND-THE EAR (BTE)
16.2.2.2.1. RECHARGABLE
16.2.2.2.1.1 MARKET VALUE (USD MN)
16.2.2.2.1.2 MARKET VOLUME (UNITS)
16.2.2.2.1.3 AVERAGE SELLINF PRICE (USD)
16.2.2.2.2. NON-RECHARGABLE
16.2.2.2.2.1 MARKET VALUE (USD MN)
16.2.2.2.2.2 MARKET VOLUME (UNITS)
16.2.2.2.2.3 AVERAGE SELLINF PRICE (USD)
16.2.2.3. POWER BEHIND-THE EAR (BTE)
16.2.2.3.1. RECHARGABLE
16.2.2.3.1.1 MARKET VALUE (USD MN)
16.2.2.3.1.2 MARKET VOLUME (UNITS)
16.2.2.3.1.3 AVERAGE SELLINF PRICE (USD)
16.2.2.3.2. NON-RECHARGABLE
16.2.2.3.2.1 MARKET VALUE (USD MN)
16.2.2.3.2.2 MARKET VOLUME (UNITS)
16.2.2.3.2.3 AVERAGE SELLINF PRICE (USD)
16.2.2.4. SINGLE-SIDED HEARING
16.2.2.4.1. RECHARGABLE
16.2.2.4.1.1 MARKET VALUE (USD MN)
16.2.2.4.1.2 MARKET VOLUME (UNITS)
16.2.2.4.1.3 AVERAGE SELLINF PRICE (USD)
16.2.2.4.2. NON-RECHARGABLE
16.2.2.4.2.1 MARKET VALUE (USD MN)
16.2.2.4.2.2 MARKET VOLUME (UNITS)
16.2.2.4.2.3 AVERAGE SELLINF PRICE (USD)
16.2.3 IN-THE-EAR HEARING AIDS
16.2.3.1. INVISIBLE-IN-THE CANAL (IIC)
16.2.3.1.1. RECHARGABLE
16.2.3.1.1.1 MARKET VALUE (USD MN)
16.2.3.1.1.2 MARKET VOLUME (UNITS)
16.2.3.1.1.3 AVERAGE SELLINF PRICE (USD)
16.2.3.1.2. NON-RECHARGABLE
16.2.3.1.2.1 MARKET VALUE (USD MN)
16.2.3.1.2.2 MARKET VOLUME (UNITS)
16.2.3.1.2.3 AVERAGE SELLINF PRICE (USD)
16.2.3.2. COMPLETELY-IN-THE CANAL (CIC)
16.2.3.2.1. RECHARGABLE
16.2.3.2.1.1 MARKET VALUE (USD MN)
16.2.3.2.1.2 MARKET VOLUME (UNITS)
16.2.3.2.1.3 AVERAGE SELLINF PRICE (USD)
16.2.3.2.2. NON-RECHARGABLE
16.2.3.2.2.1 MARKET VALUE (USD MN)
16.2.3.2.2.2 MARKET VOLUME (UNITS)
16.2.3.2.2.3 AVERAGE SELLINF PRICE (USD)
16.2.3.3. IN-THE CANAL (ITC)
16.2.3.3.1. RECHARGABLE
16.2.3.3.1.1 MARKET VALUE (USD MN)
16.2.3.3.1.2 MARKET VOLUME (UNITS)
16.2.3.3.1.3 AVERAGE SELLINF PRICE (USD)
16.2.3.3.2. NON-RECHARGABLE
16.2.3.3.2.1 MARKET VALUE (USD MN)
16.2.3.3.2.2 MARKET VOLUME (UNITS)
16.2.3.3.2.3 AVERAGE SELLINF PRICE (USD)
16.2.3.4. MINI-CANAL (MC) HEARING AIDS
16.2.3.4.1. RECHARGABLE
16.2.3.4.1.1 MARKET VALUE (USD MN)
16.2.3.4.1.2 MARKET VOLUME (UNITS)
16.2.3.4.1.3 AVERAGE SELLINF PRICE (USD)
16.2.3.4.2. NON-RECHARGABLE
16.2.3.4.2.1 MARKET VALUE (USD MN)
16.2.3.4.2.2 MARKET VOLUME (UNITS)
16.2.3.4.2.3 AVERAGE SELLINF PRICE (USD)
16.2.3.5. MICROPHONE-IN-HELIX (MIH) HEARING AIDS
16.2.3.5.1. RECHARGABLE
16.2.3.5.1.1 MARKET VALUE (USD MN)
16.2.3.5.1.2 MARKET VOLUME (UNITS)
16.2.3.5.1.3 AVERAGE SELLINF PRICE (USD)
16.2.3.5.2. NON-RECHARGABLE
16.2.3.5.2.1 MARKET VALUE (USD MN)
16.2.3.5.2.2 MARKET VOLUME (UNITS)
16.2.3.5.2.3 AVERAGE SELLINF PRICE (USD)
16.2.4 OTHER HEARING AID DEVICES
16.3 HEARING IMPLANTS
16.3.1 COCHLEAR IMPLANTS
16.3.1.1. BY PROCESSOR
16.3.1.1.1. BEHIND THE EAR PROCESSOR
16.3.1.1.1.1 MARKET VALUE (USD MN)
16.3.1.1.1.2 MARKET VOLUME (UNITS)
16.3.1.1.1.3 AVERAGE SELLINF PRICE (USD)
16.3.1.1.2. BODY WORN PROCESSOR
16.3.1.1.2.1 MARKET VALUE (USD MN)
16.3.1.1.2.2 MARKET VOLUME (UNITS)
16.3.1.1.2.3 AVERAGE SELLINF PRICE (USD)
16.3.1.2. BY TYPE
16.3.1.2.1. ABUTEMENT
16.3.1.2.2. MAGNET
16.3.1.2.3. HEADBAND
16.3.1.3. BY PPS RATE
16.3.1.3.1. 32000 PPS
16.3.1.3.2. 51000 PPS
16.3.1.3.3. 82000 PPS
16.3.1.4. BY BATTERY
16.3.1.4.1. RECHARGEABLE
16.3.1.4.2. NON RECHARGEABLE
16.3.2 BONE CONDUCTION DEVICES
16.3.2.1. BY PROCESSOR
16.3.2.1.1. BEHIND THE EAR PROCESSOR
16.3.2.1.1.1 MARKET VALUE (USD MN)
16.3.2.1.1.2 MARKET VOLUME (UNITS)
16.3.2.1.1.3 AVERAGE SELLINF PRICE (USD)
16.3.2.1.2. BODY WORN PROCESSOR
16.3.2.1.2.1 MARKET VALUE (USD MN)
16.3.2.1.2.2 MARKET VOLUME (UNITS)
16.3.2.1.2.3 AVERAGE SELLINF PRICE (USD)
16.3.2.2. BY TYPE
16.3.2.2.1. ABUTEMENT (PERCUTANEOUS)
16.3.2.2.2. HEADBANDS
16.3.2.2.3. MAGNETS (TRANSCUTANEOUS)
16.3.2.3. BY BATTERY
16.3.2.3.1. RECHARGEABLE
16.3.2.3.2. NON RECHARGEABLE
16.3.3 MIDDLE EAR IMPLANTS
16.3.3.1. BY PROCESSOR
16.3.3.1.1. BEHIND THE EAR PROCESSOR
16.3.3.1.1.1 MARKET VALUE (USD MN)
16.3.3.1.1.2 MARKET VOLUME (UNITS)
16.3.3.1.1.3 AVERAGE SELLINF PRICE (USD)
16.3.3.1.2. BODY WORN PROCESSOR
16.3.3.1.2.1 MARKET VALUE (USD MN)
16.3.3.1.2.2 MARKET VOLUME (UNITS)
16.3.3.1.2.3 AVERAGE SELLINF PRICE (USD)
16.3.3.2. BY TRANSDUCERS
16.3.3.2.1. PIEZOELECTRIC
16.3.3.2.2. ELECTROMAGNETIC
16.3.4 AUDITORY BRAIN STEM IMPLANTS
16.3.4.1. BYB PROCESSOR
16.3.4.1.1. BEHIND THE EAR PROCESSOR
16.3.4.1.1.1 MARKET VALUE (USD MN)
16.3.4.1.1.2 MARKET VOLUME (UNITS)
16.3.4.1.1.3 AVERAGE SELLINF PRICE (USD)
16.3.4.1.2. BODY WORN PROCESSOR
16.3.4.1.2.1 MARKET VALUE (USD MN)
16.3.4.1.2.2 MARKET VOLUME (UNITS)
16.3.4.1.2.3 AVERAGE SELLINF PRICE (USD)
16.3.4.2. BY ABI CHANNEL
16.3.4.2.1. SINGLE CHANNEL ABI SYSTEM
16.3.4.2.2. MULTI CHANNEL ABI SYSTEM
16.4 HEARING AID ACCESSORIES
16.4.1 HEARING AID BATTERIES
16.4.1.1. MARKET VALUE (USD MN)
16.4.1.2. MARKET VOLUME (UNITS)
16.4.1.3. AVERAGE SELLINF PRICE (USD)
16.4.2 WIRELESS ACCESSORIES
16.4.2.1. MICROPHONE
16.4.2.1.1. MARKET VALUE (USD MN)
16.4.2.1.2. MARKET VOLUME (UNITS)
16.4.2.1.3. AVERAGE SELLINF PRICE (USD)
16.4.2.2. RECEIVER
16.4.2.2.1. MARKET VALUE (USD MN)
16.4.2.2.2. MARKET VOLUME (UNITS)
16.4.2.2.3. AVERAGE SELLINF PRICE (USD)
16.4.2.3. REMOTE
16.4.2.3.1. MINI REMOTE MICROPHONE
16.4.2.3.1.1 MARKET VALUE (USD MN)
16.4.2.3.1.2 MARKET VOLUME (UNITS)
16.4.2.3.1.3 AVERAGE SELLINF PRICE (USD)
16.4.2.3.2. STANDARD REMOTE MICROPHONE
16.4.2.3.2.1 MARKET VALUE (USD MN)
16.4.2.3.2.2 MARKET VOLUME (UNITS)
16.4.2.3.2.3 AVERAGE SELLINF PRICE (USD)
16.4.3 HEARING PROTECTION
16.4.3.1. MARKET VALUE (USD MN)
16.4.3.2. MARKET VOLUME (UNITS)
16.4.3.3. AVERAGE SELLINF PRICE (USD)
16.4.4 WAX GUARD FILTERS
16.4.4.1. MARKET VALUE (USD MN)
16.4.4.2. MARKET VOLUME (UNITS)
16.4.4.3. AVERAGE SELLINF PRICE (USD)
16.4.5 OTHERS
17 BRAZIL HEARING AIDS MARKET, BY HEARING LOSS TYPE
17.1 OVERVIEW
17.2 SENSORINEURAL HEARING LOSS
17.2.1 HEARING AID DEVICES
17.2.1.1. RECEIVER-IN-THE-EAR HEARING AIDS
17.2.1.2. BEHIND-THE-EAR HEARING AIDS
17.2.1.3. IN-THE-EAR HEARING AIDS
17.2.1.4. OTHER HEARING AID DEVICES
17.2.2 HEARING IMPLANTS
17.2.2.1. COCHLEAR IMPLANTS
17.2.2.2. BONE CONDUCTION DEVICES
17.2.2.3. MIDDLE EAR IMPLANTS
17.2.2.4. AUDITORY BRAIN STEM IMPLANTS
17.2.3 HEARING AID ACCESSORIES
17.2.3.1. HEARING AID BATTERIES
17.2.3.2. WIRELESS ACCESSORIES
17.2.3.3. HEARING PROTECTION
17.2.3.4. WAX GUARD FILTERS
17.2.3.5. OTHERS
17.3 CONDUCTIVE HEARING LOSS
17.3.1 HEARING AID DEVICES
17.3.1.1. RECEIVER-IN-THE-EAR HEARING AIDS
17.3.1.2. BEHIND-THE-EAR HEARING AIDS
17.3.1.3. IN-THE-EAR HEARING AIDS
17.3.1.4. OTHER HEARING AID DEVICES
17.3.2 HEARING IMPLANTS
17.3.2.1. COCHLEAR IMPLANTS
17.3.2.2. BONE CONDUCTION DEVICES
17.3.2.3. MIDDLE EAR IMPLANTS
17.3.2.4. AUDITORY BRAIN STEM IMPLANTS
17.3.3 HEARING AID ACCESSORIES
17.3.3.1. HEARING AID BATTERIES
17.3.3.2. WIRELESS ACCESSORIES
17.3.3.3. HEARING PROTECTION
17.3.3.4. WAX GUARD FILTERS
17.3.3.5. OTHERS
18 BRAZIL HEARING AIDS MARKET, BY PATIENT TYPE
18.1 OVERVIEW
18.2 GERIATRIC
18.3 ADULTS
18.4 PEDIATRICS
19 BRAZIL HEARING AIDS MARKET, BY TECHNOLOGY
19.1 OVERVIEW
19.2 DIGITAL SIGNAL PROCESSING
19.3 SMARTPHONE COMPATIBLE
19.4 ARTIFICIAL INTELLIGENCE
19.5 COMPRESSION
19.6 FM COMPATIBILITY
19.7 FEEDBACK MANAGEMENT SYSTEM
19.8 NOISE REDUCTION
19.8.1 DIGITAL NOISE REDUCTION
19.8.2 IMPULSE NOISE REDUCTION
19.8.3 WIND NOISE REDUCTION
19.9 DIRECTIONAL MICROPHONE SYSTEMS
19.1 DATA LOGGING
19.11 TELECOIL
19.12 OTHERS
20 BRAZIL HEARING AIDS MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.3 SPECIALTY CLINICS
20.4 HOME CARE SETTINGS
20.5 OTHERS
21 BRAZIL HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL PHARMACY
21.4 HOSPITAL PHARMACY
21.5 ONLINE SALES
21.6 OTHERS
22 BRAZIL HEARING AIDS MARKET, SWOT AND DBMR ANALYSIS
23 BRAZIL HEARING AIDS MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: BRAZIL
23.2 MERGERS & ACQUISITIONS
23.3 NEW PRODUCT DEVELOPMENT & APPROVALS
23.4 EXPANSIONS
23.5 REGULATORY CHANGES
23.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 BRAZIL HEARING AIDS MARKET, BY REGION
BRAZIL HEARING AIDS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 BRAZIL
24.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRY
25 BRAZIL HEARING AIDS MARKET, COMPANY PROFILE
25.1 SONOVA.
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 WS AUDIOLOGY A/S
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 STARKEY LABORATORIES, INC.
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 COCHLEAR LTD.
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 MED-EL MEDICAL ELECTRONICS.
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 ADVANCED BIONICS AG
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 SOLAREAR
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 MICROSON S.A.U.
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 MIRACLE-EAR (SUBSIDIARY OF AMPLIFON)
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 DEMANT A/S
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 GN HEARING A/S
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
